COVID-19: 'South Korea recovery rate nearly 45%'

COVID-19: 'South Korea recovery rate nearly 45%'

Death toll in South Korea now at 132, less than 5,000 patients under treatment

By Riyaz ul Khaliq

ANKARA (AA) - The recovery rate for coronavirus patients in South Korea is over 44%, local media reported Thursday.

According to daily Korea Herald, 4,144 COVID-19 patients -- 44.8% of South Korea’s total 9,421 cases -- have "made full recoveries" since the country reported its first case on Jan. 20.

The number of cases reached 9,421 after 104 more were confirmed by the Korea Centers for Disease Control and Prevention on Wednesday, along with six fatalities that raised the death toll to 132, Yonhap News Agency reported.

This was the 15th consecutive day that South Korea reported 100 or less cases.

A total of 4,966 patients remain under treatment, 56 of them in critical condition, while 414 were discharged from hospitals on Thursday.

Both reports noted a rise in imported cases in South Korea, with the Korea Herald saying 86 of this week’s new cases were from Europe, 45 from the U.S., and eight from Asia.

The report said 284 of South Korea’s total number of cases were people who had come from abroad.

The government will start imposing 14-day mandatory self-quarantine for arrivals from the U.S. starting Friday.

A total of 364,942 people have been tested for the coronavirus in South Korea since Jan. 20, with 341,332 testing negative and 14,369 are awaiting test results, according to the Korea Herald.

After first appearing in Wuhan, China, last December, the novel coronavirus has spread to at least 175 countries and territories, according to data compiled by the U.S.-based Johns Hopkins University.

The data shows more than 472,700 cases have been reported worldwide since last December, with the death toll above 21,300 and over 115,000 successful recoveries.

Kaynak:Source of News

This news has been read 226 times in total

ADD A COMMENT to TO THE NEWS
UYARI: Küfür, hakaret, rencide edici cümleler veya imalar, inançlara saldırı içeren, imla kuralları ile yazılmamış,
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.
Previous and Next News